Announced
Completed
Financials
Sources
Tags
Majority
Acquisition
Single Bidder
Completed
Biotechnology
Private
Friendly
probiotics
Ireland
Cross Border
Synopsis
Novozymes, a global biotechnology company, completed the acquisition of PrecisionBiotics Group, a provider of probiotics for human gut health, for $90m. “By becoming a part of Novozymes, we will get a global presence across businesses and new capabilities within science and discovery of new strains. This will help us to grow by developing new products where we can combine enzymes and probiotics,” Barry Kiely, PrecisionBiotics CEO and Co-Founder.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.